• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FISHER & PAYKEL HEALTHCARE LTD AIRVO2 HUMIDIFIER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FISHER & PAYKEL HEALTHCARE LTD AIRVO2 HUMIDIFIER Back to Search Results
Model Number PT101
Device Problem Device Operates Differently Than Expected (2913)
Patient Problems Death (1802); Pneumothorax (2012); Multiple Organ Failure (3261)
Event Date 07/31/2014
Event Type  Death  
Event Description
A hospital in (b)(6) reported that a patient had died on (b)(6) 2014.Prior to the incident the patient had been on nasal high flow (optiflow) therapy using a pt101 airvo humidifier.After 48 hours of optiflow treatment, the patient was reported to have developed a pneumomediastinum (air in the cavity between the lungs).It was further reported that the patient was using a high concentration oxygen mask system for 14 days prior to being put on the optiflow system.The patient was over (b)(6) years old.We were informed that the cause of death was multiple organ dysfunction syndrome (mods) without any single cause identified.
 
Manufacturer Narrative
(b)(4).Neither the opt844 nasal interface nor the airvo2 humidifier were returned to fisher & paykel healthcare for evaluation.The hospital has not alleged any defect with either the airvo2 humidifier or the opt844 nasal interface., and the hospital continues to use the airvo2 humidifier.Our investigation is accordingly based on the description of events and our knowledge of the products and the optiflow therapy.Upon receipt of this complaint, additional information, including cause of death, was sought from the hospital.The airvo is a humidifier with integrated flow generator that delivers warmed and humidified respiratory gases to spontaneously breathing patients through a variety of patient interfaces.The opt844 interface is used to deliver humidified oxygen to patients.It consists of a lightweight delivery tube which is connected to a rigid plastic base and soft nasal prongs (nasal interface).The interface is held in place by a head strap and also includes a lanyard which is placed around the patient's neck or attached to the patient's clothing or bedding to remove the load of the breathing circuit from the patient's nares.The hospital has reported that the patient developed pneumomediastinum and subsequently died.There is no evidence to suggest that the patient's death was caused by the opiflow therapy, the cause of death having been reported as multiple organ dysfunction syndrome.With optiflow, the patient is being supported with pressures which would have been significantly lower than when the patient was ventilated with a ventilator or cpap therapy.Airway pressures of around 30cmh2o are typical with use of a ventilator, whereas optiflow pressures are typically around 3 to 4cmh2o.There are many non-optiflow related reasons which could have resulted in a pneumomediastinum.For example, it is possible that the patient developed a spontaneous pneumomediastinum which was associated with severe pathophysiology of the lungs.It was reported that the patient had pneumocystosis.This is the only complaint of this nature we have received for the optiflow system.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AIRVO2 HUMIDIFIER
Type of Device
AIRVO2 HUMIDIFIER
Manufacturer (Section D)
FISHER & PAYKEL HEALTHCARE LTD
15 maurice paykel place
east tamaki
auckland, 2013
NZ  2013
Manufacturer (Section G)
FISHER & PAYKEL HEALTHCARE LTD
15 maurice paykel place
east tamaki
auckland, 2013
NZ   2013
Manufacturer Contact
raymond yan
15365 barranca parkway
irvine, CA 92618-2216
9494534000
MDR Report Key4062297
MDR Text Key4813430
Report Number9611451-2014-00749
Device Sequence Number1
Product Code BTT
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K131895
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 08/06/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberPT101
Device Catalogue NumberPT101
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/06/2014
Initial Date FDA Received09/05/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
FISHER & PAYKEL OPT844 ADULT NASAL CANNULA
Patient Outcome(s) Death; Hospitalization;
Patient Age80 YR
-
-